DAFTAR PUSTAKA Abbas, AK, Lichtman, AH and Pillai, S., 2012

144

DAFTAR PUSTAKA

Abbas, A.K., Lichtman, A.H. and Pillai, S., 2012. Cellular and Molecular

Immunology, 7th ed., Elsevier Saunders.

Abraham, R.T. and Gibbons, J.J., 2007. The mammalian target of

rapamycin signaling pathway: twists and turns in the road to

cancer therapy. Clin Cancer Res, 13(11), pp. 3109-14.

Adhikari, N.K., Fowler, R.A., Bhagwanjee ,S., Rubenfeld, G.D., 2010.

Critical care and the global burden of critical illness In adults. The

Lancet, 376(9749), pp. 1339- 46.

Ahmad, A.M., Hopkins, M.T., Thomas, J., Ibrahim, H., Fraser, W.D. and

Vora, J.P., 2001. Body Composition and Quality of Life in Adults

with Growth Hormone eficiency; effect of low-dose hormone

replacement. Clinical Endocrinology, 54 (6), pp. 709-17.

Ahmed, T.A., Buzelli, M.D., Lang, C.H., Capen, J.B., Shumate, M.L.,

Navaratnarajah, M., et al., 2007. Interleukin-6 inhibits growth

hormone-mediated gene expression in hepatocytes. Am J Physiol

Gastrointest liver Physio, March, p. 292.

Al-Shoumer, K.A., Anyaoku, V., Richmond, W. and Johnston, D.G., 1997.

Elevated leptin concentrations in growth hormone-deficient

hipopituitary adults. Clinical Endocrinol, 47, pp.153-159.

Allen, D.B., 1996. Growth suppression by glucocorticoid therapy.

Endocrinol Metab Clin, 25(3), pp. 699-717.

Alscher, K.T., Phang, P.T., McDonald, T.E. and Walley, K.R., 2001.

Enteral Feeding Decreases Gut Apoptosis, Permeability ang Lung

Inflammation during Murine Endotoxemia. Am J Physiol

Gastrointest Liver Physiol, 281(2), pp. 569-76

Angele, M.K., Frantz, M.C. and Chaudry, I.H., 2006. Gender and sex

hormones influence the response to trauma and sepsis – potential

therapeutic approaches. Clinics, 61(5), pp. 479-88.

144

Universitas Sumatera Utara

145

Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J.,

Pinsky, M.R., 2001. Epidemiology of severe sepsis in the United

States: Analysis of incidence, outcome, and associated costs of

care. Crit. Care Med., 29(7), pp. 1303-10.

Arul, M.C., Markus, H.L., Chandan, K.S., Terrence, R.B., Sunita, S.S.,

Vidya, J.S., et al., 2001. Molecular Signatures of Sepsis

Multiorgan Gene Expression Profiles of Systemic Inflamation. Am

J Pathol October, 159(4), pp. 1199-1209.

Ashare, A., Doerschug, K.C., Nymon, M.M., Schmidt, M.D. and

Hunninghake, G.W., 2009. Low levels of IGF-1 correlate with the

development of bacterial translocation in sepsis. Am J Respir Cit

Care Med,179.

Ashare, A., Nymon, A.B., Doerschug, K.C., Morrison, J.M., Monick, M.M.,

Hunninghake, G.W., 2008. Insulin-like growth factor-1 improves

survival in sepsis via enhanced hepatic bacterial clearance. Am J

Respir Crit Care Med, Jul 15; 178(2); 149-57.

Astiz, M.E. and Rackow, E.C.,1998. Septic shock. Lancet, 351, pp.1501-5.

Balk, R.A., Ely, E.W. and Goyette, R.E.,2004. Sepsis handbook. 2nd

edition. Society of Cricital Care.

Ball, S. and Baudouin, S.V., 2010. The endocrine response to critical

illness, in : Core Topics in Endocrinology in Anaesthesia and

Critical Care, Eds. Hall, G.M., et al. Cambridge University Press,

Sect. 3, Ch. 13, pp. 125-33.

Balteskard, L., Unneberg, K., Mjaaland, M., Sager, G., Jenssen, T.G. and

Revhaug, A., 1998. Treatment with growth hormone an insulin like

growth factor in septicemia : Effect on carbohydrate metabolism.

Eur Surg Res, 30, pp. 79-94.

Barinaga, M., Yamamoto, G. and Rivier, C., 1993. Transcriptional

regulation of growth hormone gene expression by growth

hormone releasing factor. Nature, 306, pp. 84-5.


146

Barlund, M., Monni, O., Kononen, J., Cornelison, R., Torhorst, J., Sauter,

G., et al., 2000. Multiple genes at 17q23 undergo amplification and

overexpression in breast cancer. Cancer Res, 60(19), pp. 5340-4.

Basaria, S., Coviella, A.D., Travison, T.G., Storer, T.W., Farwell, W.R.,

Jette, A.M., et al., 2010. Adverse Events Associated with

Testosterone Administration. N Engl J Med, 363, pp. 109-22.

Bauer, P., Charpentier, C., et al.,2000. Pareenteral with enteral nutrition in

the critically ill. Intensive Care Med, 26, pp 893-900.

Beck, F.K. and Rosenthal, T.C., 2002. Prealbumin: A Marker for Nutritional

Evaluation. Am Fam Physician, 65, pp.1575-8.

Berghe, G.V.D., 2003. Endocrine evaluation of patients with critical illness.

Endocrine Metab Clin N Am, 32, pp. 385-410.

Berghe, G.V.D., Wouters, P., Bowers, C.Y., de Zegher, F., Bouillion, R.,

and Veldhuis, J.D., 1999. Growth hormone-releasing peptide-2

infusion synchronizes growth hormone, thyrotrophin and prolactin

release in prolong critical illness. European journal of

Endocrinology, 140, pp. 17-22.

Berghe, G.V.D., 2000. Novel insights into the neuroendocrinology of

critical illness. European journal of Endocrinology, 143, pp. 1-13.

Berne, R., 2000. Principles of Physiology. 3rd edition. Missouri, Mosby

Inc, pp. 540-4.

Besser and Thorner, 2007. Comprehensive Clinical Endocrinology, 3rd

edition. Elsevier Sciences Ltd.

Bideci, A. and Camurdan, O., 2009. Physiology of Growth Hormone

Secretion. J Clin Res Ped Endo, 1, pp. 1–7.

Blackmann, M.R., Sorkin, J.D., Munzer, T., Bellantoni, M.F., Whitehead,

J.B., Stevens, T.E., et al., 2002. Growth hormone and sex steroid

administration in healthy aged women and men. JAMA, 288(18),

pp. 2282-92.

Blackwell and Christman, J.W., 2006. Sepsis and Cytokines: Current

Status. British Journal of Anaesthesia, 77, pp. 110-7.


147

Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus,

W.A., et al., 1992. Definition for sepsis and organ failure and

guidelines for the use of innovative therapies in sepsis. The

ACCP/SCCM Consensus Conference. Chest, 101, pp. 1644-55.

Bone, R.C., 1991. Critical evaluation of new agents for the treatment of

sepsis. JAMA, 266, pp. 1686-91.

Bone, R.C., 1994. Gram positive organism and sepsis. Arch Intern Med,

154, pp. 26-34.

Bone, R.C., Grodzin, C.J. and Balk, R.A., 1997. Sepsis : a new hypothesis

for pathogenesis of disease process. Chest, 112, pp. 235-43.

Bone, R.C., Sir Isaac Newton, 1996. Sepsis, SIRS and CARS. Crit Care

Med, 24, pp. 1125-8.

Bone, R.C., 1991. The pathogenesis of sepsis. Ann of Intern Med, 115,

pp. 457-69.

Brown, R.J., Adam, J.J. and Pelekanos, R.D., 2005. Model for growth

hormone receptor activation based on subunit rotation within a

receptor dimer. Nat Struct Mol Biol, 12, pp. 814-21.

Brown, E.J., Beal, P.A., Keith, C.T., Chen, J., Shin, T.B. and Schreiber,

S.L., 1995. Control of p70S6 kinase by Kinase Activity of FRAP in

vivo. Nature, 377(6548), pp. 441-6.

Burnett, P.E., Barrow, R.K., Cohen, N.A., Snyder, S.H. and Sabatini, D.M.,

1998. RAFT1 phosphorylation of the translational regulators p70

S6 kinase and 4E-BP1. Proc Natl Acad Sci, 95(4), pp. 1432-7.

Carro, E., Senaris, R. and Considine, R.V., 1997. Regulation of in vivo

growth hormone secretion by leptin. Endocrinology,138, p2203- 6.

Carter, S.C., Schwartz, J. and Smith, L.S., 1996. Molecular mechanism of

growth hormone action. Annu. Rev. Physiol, 58, pp. 187-207.

Cassanueva, F.F. and Dieguez, C., 1999. Neuroendocrine regulation and

actions of leptin. Front Neuroendocrinol, 20, pp. 317-63.

Cavaillon, J. and Adire, C., 2009. Sepsis and Non-infectious Systemic

Inflammation. Weinheim, Germany. WILEY-VCH Verlag & Co.


148

Chan, S., 2004. Targeting the mammalian target of rapamycin (mTOR) : a

new approach to treating cancer. British Journal of Cancer, 91, pp.

1420–4.

Chang, Y.T., Wong, C.K., Chow, K.C. and Tsai, C.H., 2007. Apoptosis in

Primary Amyloidosis. British Journal of Dermatology, 140(2), pp.

210-5.

Chamberlain, R.N., 2004, From Systemic Inflammatory Response

Syndrome (SIRS) To Bacterial Sepsis With Shock. Available from:

http://www.atsu.edu/faculty/chamberlain/Website/lectures/lecture/s

epsis.htm. Accessed at Dec. 17th 2014.

Chen, Y., Sood, S., Krishnamurthy, V.M.R., Rotwein, P. and Rabkin, R.,

2009. Endotoxin-Induced Growth Hormone Resistance in Skeletal

Muscle. Endocrinology, 150, pp. 3620–6

Chen, G., Shaw, M.H., Kim, Y.G., Nunez, G., 2009. NOD-like receptors:

role in innate immunity and inflammatory disease. Annu Rev

Pathol., 4, pp. 365-98.

Chen, F., Castranova, V., Shi, X.,2001. New Insights into the Role of

Nuclear Factor-ĸB In Cell Growth Regulation. American Journal of

Pathology, 159(2), pp. 387-97

Cheng, C.A., West, T.E., Limmathurotsakul, D., Peacock, S.J., 2008.

Strategies to Reduce Mortality from Bacterial Sepsis in Adults in

Developing Countries. PLoS Medicine, 5(8), pp.1173-9.

Chung, T.T. and Hinds, C.J., 2006. Treatment with GH and IGF-1 in

Critical Illness. Crit Care Clin, 22, pp. 29-40.

Clark, M.A., Hentzen, B.T., Plank, L.D., Hill, G.L.,1996. Sequential

changes in IGF-1, plasma protein, and total body protein in severe

sepsis and multiple injury. JPEN J Parenter Enteral Nutr, 20, pp.

363-70.

Cohen, J. and Carlet, J., 1996. INTERSEPT : an international, multicenter,

placebo controlled trial of monoclonal antibody to human tumor

necrosis factor patients with sepsis. Crit Care Med, 24, pp. 1431-4


149

Cohen, J., 2002. Insight Review Article: The Immuno-pathogenesis of

Sepsis. Brighton : Nature Publishing Group. Vol 420/19/26/Dec

Cuschieri, J., Bulger, E., Schaeffer, V., Sakr, S., Nathens, A.B., Hennessy,

L.et al., 2010. Early Elevation in Random Plasma IL-6 Following

Severe Injury is Associated with Development of Organ Failure.

Shock, 34(4), pp. 346–351.

Dandona, P., Dhindsa, S., Chandel, A. and Topiwala, S., 2009. Low

testosterone in men with type 2 diabetes – a growing public health.

Diabetes Voice, 54.

De Boer, H., Blok, G.J. and van der Veen, E.A., 1995. Clinical aspects of

growth hormone deficiency in adult. Endocrine Rev, 16, pp. 68-86.

Dellinger, R.P., Levy, M.M., Carlet, J.M., Bion, J., Parker, M.M., Jaeschke,

R., et al., 2008. Surviving Sepsis Campaign International

guidelines for management of severe sepsis and septic shock.

Intesive Care Med, 34, pp. 17-60.

Deng, L., He, K., Wang, X., Yang, N., Thangavel, C., Jiang, J., et al., 2007.

Determinants of Growth Hormone Receptor Down-Regulation.

Molecular Endocrinology, 21(7), pp.1537–51.

Dong, Q., Hawker, F., McWilliam, D., Bangah, M., Burger, H. and

Handelsman, D.J., 1992. Circulating immunoreactive inhibin and

testosterone levels In men with critical illness. Clinical

endocrinology, 36, pp. 399-404.

Doi, K., Leelahavanichkul, A., Yuen, P.S.T. and Star, R.A., 2009. Animal

models of sepsis and sepsis-induced kidney injury. J. Clin. Invest,

119, pp. 2868–78.

Elena, G.R., Alejo, C., Gema, R. and Mario, D., 2006. Cortistatin, a new

antiinflamatory peptide with therapeutic effect on lethal

endotoxemia. J Exp Med, 203(2), pp. 563-71.

Exley,A.R.,Cohen, J.,Buurman,W., Owen,R., Hanson,G., Lumley,J. et al.,

1990.Monoclonal antibody to TNF in severe septic shock Lancet,

335,1275-7


150

Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. and Chen, J.,

2001. Phosphatidic acid-mediated mitogenic activation of mTOR

signaling. Science, 294(5548), pp. 1942-5.

Farnfield, M.M., Carey, K.A., Gran, P., Trenerry, M.K. and Smith, D.C.,

2009. Whey Protein Ingestion Activates mTOR-dependent

Signalling after Resistance Exercise in Young Men: A Double-

Blinded Randomized Controlled Trial. Nutrients, 1, pp. 263-75.

Frias, M.A., Thoreen, C.C., Jaffe, J.D., Schroder, W., Sculley, T., Carr,

S.A., et al., 2006. mSin1 is necessary for Akt/PKB

phosphorylation, and its isoforms define three distinct mTORC2s.

Curr Biol, 16(18), pp. 1865-70.

Frost, R.A. and Lang, C.H., 2011. mTOR signaling in skeletal muscle

during sepsis and inflammation: Where does it all go

wrong?,Physiology (Bethesda), 26(2), pp.83–96

Ganong, W., 2005. Review of Medical Physiology. 22nd Ed. Singapore :

McGraw- Hill. p. 396-405

Gardner, David, G., Shoback and Dolores, 2007. Greenspan basic and

clinical Endocrinology, 8th ed. New York, McGraw Hill Medical. pp.

193-201.

Gellerich, F.N., Laterveer, F.D., Zierz, S. and Nicolay, K., 2002. The

quantitation of ADP diffusion gradients across the outer membrane

of heart mitochondria in the presence of macromolecules.

Biochem Biophys Acta, 1554, pp. 48-56.

Gianluigi, D. et al., 2006. Prealbumin serum concentration as useful tool in

the assessment of mnutrition in hospitalized patients. Clinic

Chemical, 52, pp 2281-85.

Giannoulis, M.G., Jackson, N., Moradje, F.S., Nair, K. S., Sonksen, P.H.,

Martin, F.C., et al., 2008. The Effects of Growth Hormone and/or

Testosterone on Whole Body Protein Kinetics and Skeletal Muscle

Gene Expression in Healthy Elderly Men : A Randomized

Controlled Trial. J Clin Endocrinol Metab, 93, pp. 3066–74.


151

Griffiths, R.D., Hinds, C.J. and Little, R.A., 1999. Manipulating the

metabolic response to injury. British Medical Bulletin, 55 (1), pp.

181-95.

Guertin, D.A. and Sabatini, D.M., 2007. Defining the role of mTOR in

cancer. Cancer Cell, 12(1), pp. 9-22.

Guillemin, R. and Gerich, J.E., 1976. Somatostatin : physiological and

clinical significance. Annu Rev Med, 27, pp. 379-88.

Guntur, A.H., 2007. Sepsis. Dalam : Buku Ajar Ilmu Penyakit Dalam. Pusat

Penerbit Ilmu Penyakit Dalam FK UI. Jilid III . Edisi ke-4,

Jakarta,. hal.1840-43

Gupta, S., Purcell, N.H., Lin, A. and Sen, S.,2002. Activation of NFkB is

necessary for myotrophin-induced cardiac hypertrophy. The

Journal of Cell Biology,159(6), pp.1019–28.

Gurbuz, N., Mammadov, E. and Usta, M.F., 2008. Hypogonadism and

erectile dysfunction: an overview. Asian J Androl, 10, pp. 36–43.

Hansen, J.A., Lindberg, K., Hilton, D.J., Nielsen, J.H. and Billestrup, N.,

1999. Mechanism of Inhibition of Growth Hormone Receptor

Signaling by Suppressor of Cytokine Signaling Proteins. Molecular

Endocrynology, 13(11), pp. 1832-43.

Haren, M.T., Siddiqui, A.M., Armbrecht, H.J., Kevorkian, R.T., Kim, M.J.,

Haas, J., et al., 2009. Testosterone modulates gene expression

pathways regulating nutrient accumulation, glucose metabolism

and protein turnover in mouse skeletal muscle. International

Journal of Andrology, 34, pp. 55–68.

Hartman, M.L., Veldhuis, J.D. and Jhonson, M.L., 1992. Augmented

Growth Hormone(GH)secretory burst frequency and amplitude

mediate enhanced GH secretion during a two-day fast in normal

men. J. Clin. Endocrinal Metab, 74, pp. 757-65

Hatton, J., Kryscio, R., Ryan, M., Ott. L. and Young, B., 2006. Systemic

metabolic effects of combined insulin-like growth factor-1 and

growth hormone therapy in patients who have sustained acute

traumatic brain injury. J Neurolsurg, 105, pp. 843-52.


152

Hay, N. and Sonenberg, N., 2004. Upstream and downstream of mTOR.

Genes Dev, 18(16), pp. 1926-45.

Ho, J.T., Al-Musalhi, H., Chapman, M.J., Quach, T., Thomas, P.D.,

Bagley, C.J., et al., 2006. Septic Shock and Sepsis: A Comparison

of Total and Free Plasma Cortisol Levels. J Clin Endocrinol

Metab, 91, pp.105-14.

Hotchkiss, R.S. and Karl, I.E., 2003. The pathophysiology and treatment of

sepsis. New Engl J Med, 348(2), pp.138-50.

Isotani, S., Hara, K., Tokunaga, C., Inoue, H., Avruch, J. and Yonezawa,

K., 1999. Immunopurified mammalian target of rapamycin

phosphorylates and activates p70 S6 kinase alpha in vitro. J Biol

Chem, 274(48), pp. 34493-8.

John, R.C. and Dorinski, P.M., 1993. Immunologic therapy for ARDS,

septic shock and multiple organ failure. Chest, 103, pp. 932-43.

Juul, A., Jorgensen, J.O., Christiansen, J.S., Muller, J. and Skakkeboek,

N.E., 1995. Metabolic effects of GH: a rationale for continued GH

treatment of GHdeficient adult after cessation of linear growth.

Horm Res, 44 (3), pp. 64-72.

Kanaley, J.A., Weltman, J.Y., Veldhuis, J.D., Rogol, A.D., Hartman, R.L.

and Weltman, A., 1997. Human growth hormone respon to

repeated bout aerobic exercise.J Appl Physiol, 83(5), pp. 1756-61.

Kazi, A.A., Pruznak, A.M., Frost, R.A. and Lang, C.H.,2011. Sepsis-

Induced Alterations in Protein-Protein Interactions within mTOR

Complex 1 and The Modulating Effect of Leucine on Muscle

Protein Synthesis. Shock, 35(2), pp. 117–125.

Khardori, R., Adamski, A. and Khardori, N., 2007. Infection, Immunity, and

Hormones/Endocrine Interactions. Infect Dis Clin N Am, 21, pp.

601–15.

Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R. and Tempst,

P., et al., 2002. mTOR interacts with raptor to form nutrient-

sensitive complex that signals to the cell growth machinery. Cell,

110(2), pp. 163-75.


153

Kinasewitz, G.T., Yan, S.B., Basson, B., Comp, P., Russell, J.A., Cariou,

A., et al., 2004. Universal changes in biomarkers of coagulation

and inflammation occur in patients with severe sepsis, regardless

of causative micro-organism, Critical Care, 8(2), pp. 82-90.

King, M.W., 2006. Structure and Function of Hormones : Growth Hormone.

Indiana State University.

Kojima, M., Hosoda, H. and Date, Y., 1999. Ghrellin is a growth-hormone

releasing acylated peptide from stomach. Nature, 402, pp. 656-60.

Kreimmer, U. and Peter, K., 1998. Strategies of volume therapy in sepsis

and systemic inflammatory syndrome. Kidney International, 64, pp.

75-9.

Kristine, M.J., Lindboe, S.B., Petersen, A.L., Olsen, J.E. and Benfield, T.,

2007. Common TNF-α, IL-1β, PAI-1, uPA, CD14 dan TLR4

polymorphisms are not associated with disease severity or

outcome from Gram negative sepsis. BMC Infect Dis, 7, p.108

Kronenberg, H.M., Melmed, S., Polonsky, K.S. and Larsen, P.R., 2007.

William Textbook of Endocrinology. USA. Saunders, pp.198-210.

Kvetan, V., Mustafa, I. and Dobb, G., 1998. Resuscitation of patient in

septic shock. 1st Asia-Pacific Consensus Conference in Critical

Care Medicine. Crit Care and Shock, 1, pp. 57-74.

Laaksonen, D.E., Niskanen, L., Punnone, K., Tuomainen, T.P., Salonen,

R., Rauramaa, R., et al., 2003. Sex hormones, inflammation and

the metabolic syndrome: a population-based study. Eur J

Endocrinol, 149(6), pp. 601–8.

Lang, C.H., and Frost, R.A., 2007. Sepsis-induced suppression of skeletal

muscle translation initiation mediated by tumor necrosis factor-α.

Clin Chem Lab Med, 45,pp. 419–26.

Langen, R.C.J, Van der Velden, J.L.J.,V.D., Schols, A.M.W.J.,Kelders,

M.C.J.M., Wouters,E.F.M., and Janssen-Heininger, Y.M.W., 2004.

Tumor necrosis factor-alpha inhibits myogenic differentiation

through MyoD protein destabilization. Faseb J.18,pp. 227–237


154

Laplante, M. and Sabatini, D.M., 2009. An Emerging Role of mTOR in

Lipid Minireview Biosynthesis. Current Biology, 19, pp. 1046-52.

Lee, P.S., Wilhelmson, A.S.K., Hubner, A.P., Reynolds, S.B., Gallacchi,

D.A., Chiou, T.T., et al., 2010. mTORC1-S6K Activation by

Endotoxin Contributes to Cytokine Up-Regulation and Early

Lethality in Animals. Plos One, 5(12), pp. 1-8.

Leichtnam, M.L., Rolland, H., Wuthrich, P. and Guy, R.H., 2006.

Testosterone Hormone Replacement Therapy: Stateof-the-Art and

Emerging Technologies. Pharmaceutical Research, 23(6), pp.

1117-32.

Lever, A. and Mackenzie, I., 2007. Sepsis: definition, epidemiology, and

diagnosis. BMJ, 335, pp. 879-83.

Lin, C.Y., Lin, M.T., Cheng, R.T. and Chen, S.H., 2010. Testosterone

Depletion by Castration May Protect Mice from Heat-Induced

Multiple Organ Damage and Lethality. Journal of Biomedicine and

Biotechnology, Article ID 485306, pp. 1-9.

Lin, F., Zhang, P.L., Yang, X.J., Prichard, J.W., Lun, M. and Brown, R.E.,

2006. Morphoproteomic and Molecular Concomitants of an

Overexpressed and Activated mTOR Pathway in Renal Cell

Carcinomas. Annals of Clinical & Laboratory Science, 36(3), pp.

283-93.

Lin, J., Parente, J.D., Chase, J.G., Shaw, G.M., Blakemore, A.J.,

LeCompte, A.J., et al., 2009. Development of a Model-Based

Clinical Sepsis Biomarker for Critically Ill Patients. Proceedings of

the 7th IFAC Symposium on Modelling and Control in Biomedical

Systems, Aalborg, Denmark.

Lin, S.K. and Wajnrach, M.P., 2002. Growth Hormone Releasing Hormone

(GHRH) and GHRH Receptor. Rev Endocr Metab Disord, 3(4), pp.

313-23.

List, E.O., Sackmann-Sala, L., Berryman, D.E., Funk, K., Kelder, B.,

Gosney, E.S., et al., 2011. Endocrine Parameters and Phenotypes


155

of the Growth Hormone Receptor Gene Disrupted (GHR_/_)

Mouse. Endocrine Review, 32, pp. 356–86.

Liu, S.F. and Malik, A.B., 2006. NF-kB activation as a pathological

mechanism of septic shock and inflammation. Am J Physiol Lung

Cell Mol Physiol 290 : L622-L645.

Losonczy, Gy., Kriston, T., Szabo, A., Muller, V., Harvey, J., Hamar, P., et

al., 2000. Male gender predisposes to development of endotoxic

shock in the rat. Cardiovascular Research, 47, pp. 183–91.

Low, L.C., 1991. Growth Hormone Releasing Hormone : Clinical study and

therapeutic aspects. Neuro endocrinology, 53(1), pp. 37-40.

Lu, C., Kumar, P.A., Fan, Y., Sperling, M.A. and Menon, R.K., 2010. A

Novel Effect of Growth Hormone on Macrophage Modulates

Macrophage-Dependent Adipocyte Differentiation. Endocrinology,

151, pp. 2189–99.

Lynn, W.A., 1998. Anti-endotoxin therapeutic options for the treatment of

sepsis. J of Antimicrobial Chemotherapy, 41, pp. 71-80.

Makhside, N., 2005. Hypogonadism and metabolic syndrome: implications

for testosterone therapy. J Urol, 3(174), pp. 827–34.

Marshall, J.C. and Reinhart, K., 2009. Biomarkers of sepsis. Crit Care

Med, 37, pp. 2290–8.

Martin, G.S., Manino, D.M., Eaton, S. and Moss, M., 2003. The

Epidemiology of Sepsis in United States From 1979 Trough 2000.

N Engl J Med, 348, pp. 1546-54.

Matsuda, N. and Hattori, Y., 2006. Systemic Inflammatory Response

Syndrome (SIRS): Molecular Pathophysiology and Gene Therapy.

J Pharmacol Sci, 101, pp. 189–98.

Maxwell, D.K. et al., 2006. Success yields success: The surviving sepsis

campaign past, present and future. European society of intensive

care medicine.

Mehta, Ameeta, and Peter, 2002. The use of somatropin (recombinant

growth hormone) in children with short stature. Pediatric Drugs, 4,

pp. 37-47.


156

Meinhardt, U.J. and Ho, K.K., 2006. Modulation of growth hormone action

by sex steroids. Clin Endocrinol, 65(4), pp. 413-22.

McConachie, I., 2006. Handbook of ICU Therapy. 2th edition. Cambridge.

Cambridge University Press.

Molitch, M.E., Clemmons, D.R. and Matozowski, S., 2006. Evaluation and

treatment of adult growth hormone deficiency : an Endocrine

Society Clinical Practice Guideline. J Clin Endocrinol Metab, 91,

pp. 1621-34.

Moller, N. and Jorgensen, J.O.L., 2009. Effects of Growth Hormone on

Glucose, Lipid, and Protein Metabolism in Human Subjects.

Endocrine Reviews, 30(2), pp.152–77.

Montagne, J., Stewart, M.J., Stocker, H., Hafen, E., Kozma, S.C. and

Thomas, G., 1999. Drosophila S6 kinase: a regulator of cell size.

Science, 285(5436), pp. 2126-9.

Moreira, P.R., Lima, P.M.A., Sathler, K.O.B., Imanishi, S.A.W., Costa, J.E.,

Gomez, R.S., et all., 2007. Interleukin-6 expression and gene

polymorphism are associated with severity of periodontal disease

in a sample of Brazilian individuals. J Clin Exp Immunol, April,

148(1), pp. 119-26.

Munzer, T., Harman, S.M., Hees, P., Shapiro, E., Christmas, C.,

Bellantoni, M.F., et al., 2001. Effects of GH and/or Sex Steroid

Administration on Abdominal Subcutaneous and Visceral Fat in

Healthy Aged Women and Men. The Journal of Clinical

Endocrinology & Metabolism, 86(8), pp. 3604–10.

Murphy, T.J., Paterson, H.M., Mannick, J.A. and Lederer, J.A., 2004.

Injury, sepsis, and the regulation of Toll-like receptor responses. J.

Leukoc. Biol, 75, pp. 400–7.

Murray, R.K., Ganner, D.K., Mayes, P.A. and Rodwell, V.W., 2003.

Biokimia Harper. Edisi 25. Jakarta, EGC, pp. 547-66.

Murton, A.L., Alamdari, N., Gardiner., S.M., Constantin-Teodosiu, D.,

Layfield, R., Bennett, T., et al., 2009. Effects of Endotoxaemia on


157

Protein Metabolism in Rat Fast-Twitch Skeletal Muscle and

Myocardium. Plos One, 4(9), pp. 1-8.

Nightingale, C.H., Murakawa, T. and Ambrose, P.G., 2001. Antimicrobial

Pharmacodynamics in Theory and Clinical Practice. New York.

Marcel Dekker Inc.

Nindl, B.C., Hymer, W.C., Deaver,D.R. and Kraemer, W.J., 2001. Growth

hormone pulsatility profile characteristic following acute heavy

resistance exercise. J. Appl. Physiol, 91(1), pp. 163-72.

Nojima, H., Tokunaga, C., Eguchi, S., Oshiro, N., Hidayat, S., Yoshino, K.,

et al., 2003. The mammalian target of rapamycin (mTOR) partner,

raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1

through their TOR signaling (TOS) motif. J Biol Chem, 278(18),

pp. 15461-4.

Norrelund, H., 2005. The metabolic role of growth hormone in humans with

particular reference to fasting. Growth Hormone. IGF Res, 15(2),

pp. 95-122.

Pangkahila, W. 2007. Anti Aging Medicine : Memperlambat Penuaan,

Meningkatkan Kualitas Hidup. Cetakan ke-1. Jakarta : Penerbit

Buku Kompas, pp. 1-3, 8-9, 37-40, 216.

Parnham, M.J., Dauphinee, S.M. and Karsan, A., 2010. Endothelial

Dysfunction and Inflammation. Switzerland. Springer Science.

Parrat, J., 1994. Nitric Oxide in sepsis and endotoxaenemia. J of

Antimicrobial Chemotherapy, 41, pp. 31-9.

Pearce, L.R., Alton, G.R., Richter, D.T., Kath, J.C., Lingardo, L.,

Chapman, J., et al., 2010. Characterization of PF-4708671, a

novel and highly specific inhibitor of p70 ribosomal S6 kinase

(S6K1). Biochem J, 431(2), pp. 245-55.

Pedoman Nasional Etik Penelitian Kesehatan, Suplemen II Etik

Penggunaan Hewan Percobaan, 2006. Komisi Nasional Etik

Penelitian Kesehatan. Departemen Kesehatan RI. Jakarta.

Pedoman Nasional Etik Penelitian Kesehatan, 2007. Komisi Nasional Etik

Penelitian Kesehatan. Departemen Kesehatan RI. Jakarta.


158

Pescovitz, O.H., Rogol, A. and Rosenfeld, R., 2003. Growth Hormone

Issues in Children and Adults. Get the Facts. Connecticut. The

Hormone Foundation.

Playfair, J.H.L. and Chain, B.M., 2001. Immunology at a Glance. 7th

edition. Oxford. Blackwell Science Ltd.

Pierrakos, C. and Vincent, J.L., 2010. Sepsis biomarkers: a review. Critical

Care, 14(15), pp. 1-18.

Powers, M., 2005. Performance-Enhancing Drugs. Principles of

Pharmacology for Athletic Trainers. Slack Incorporated, pp. 331-2.

Price, D.J., Grove, J.R., Calvo, V., Avruch, J. and Bierer, B.E., 1992.

Rapamycin-induced inhibition of the 70-kilodalton S6 protein

kinase. Science, 257(5072), pp. 973-7.

Qureshi, K. and Rajah, A., 2008. Septic shock: A review article. BJMP,

1(2), pp. 7-12.

Raguso, C.A., et al., 2003. The role of visceral protein in the nutritional

assessment of ICU patients. Curr Opin Clin Nutr Metab Care, 6,

pp.211-16

Reiling, J.H. and Sabatini, D.M., 2006. Stress and mTORture signaling.

Oncogene, 25(48), pp. 6373-83.

Reiling, J.H. and Sabatini, D.M., 2008. Increased mTORC1 Signaling

UPRegulates Stress. Molecular Cell, 29, pp. 533-35.

Reinhart, K. and Sakr, Y., 2003. Development in sepsis: past, present and

future. Intensetimes. November, 3, pp. 56-72.

Rello, J., Diaz, E., Rodriguez, A., (eds), 2009. Management of Sepsis :

The PIRO Approach. Springer-Verlag Berlin Heidelberg.

Remick, D.G., 2007. Biological Perspectives, Pathophysiology of Sepsis.

The American Journal of Pathology, 170(5), pp. 1435-44.

Rennie, M.J., 2003. Claims for the anabolic effects of growth hormone: a

case of the Emperor’s new clothes ? Br J Sports Med, 37, pp.

100–5.


159

Rittirsch, D., Hoesel, L.M. and Ward, P.A., 2007. The disconnect between

animal models of sepsis and human sepsis. J. Leukoc. Biol, 81,

pp. 137–143.

Rittirsch, D., Flierl, M.A. and Ward, P.A., 2008. Harmful molecular

mechanisms in sepsis. Nat Rev Immunol, 8(10), pp. 776–87.

Robeva, R., Kirilov, G., Tomova, A. and Kumanov, P., 2006. Low

testosterone levels and unimpaired melatonin secretion in young

males with metabolic syndrome. Andrologia, 38(6), pp. 216–20.

Russell, J.A., 2006. Management of Sepsis. N Engl J Med, 355, pp. 1699-

713.

Sadler, T., 2004. Langman’s Medical Embryology 9th edition. Baltimore.

Lipincott Williams and Wilkins, pp. 455–6.

Saenger, P., 2009. Current Status of Biosimilar Growth Hormone.

International Journal of Pediatric Endocrinology, Article ID 370329,

pp. 1-6.

Salomon, F., Cuneo, R.C., Hesp, R. and Sonksen, P.H., 1989. The effect

of treatment with recombinant human growth hormone on body

composition and metabolism in adult with growth hormone

deficiency. N. Engl. J. Med, 321, pp. 1797-1803.

Sarbassov, D.D., Ali, S.M., Kim, D.H., Guertin, D.A., Latek, R.R., Sabatini,

D.M., et al., 2004. Rictor, a novel binding partner of mTOR,

defines a rapamycin-insensitive and raptor-independent pathway

that regulates the cytoskeleton. Curr Biol, 14(14), pp. 1296-302.

Sarbassov, D.D., Ali, S.M. and Sabatini, D.M., et al., 2005. Growing roles

for the mTOR pathway. Current Opinion in Cell Biology, 17, pp.

596–603.

Scarth, J.P., 2006. Modulation of the growth hormone –insuline-like growth

factor GH-IGF) axis by pharmaceutical, nutraceutical and

enviromental xenobiotics : an emereging role for xenobiotics –

metabolizing enzymes and the transcription factors regulating their

expression. A review Xenobiotica, 36(2-3), pp. 119-218.


160

Schieke, S.M., Phillips, D., McCoy, J.P., Aponte, A.M., Shen, R.F.,

Balaban, R.S., et al., 2006. The Mammalian Target of Rapamycin

(mTOR) Pathway Regulates Mitochondrial Oxygen

Consumptionand Oxidative Capacity. The Journal of Biological

Chemistry, 281( 37), pp. 27643–52.

Shapiro, N.I., Scguetz, P., Yano, K., Sorasaki, M., Parikh, S.M., Jones,

A.E., et al., 2010. The association of endothelial cell signaling,

severity of illness, and organ dysfunction in sepsis. Critical Care,

14(182), pp. 1-12.

Shavdia, D., 2007. Septic shock: Providing early warning through

multivariate logistic regression. Harvard –MIT division of health

sciences & technology.

Shi, J., Sekhar, R. V., Balasubramanyam, A., Ellis, K., Reeds, P.J.,

Jahoor, F., et al., 2003. Short- and Long-Term Effects of Growth

Hormone (GH) Replacement on Protein Metabolism in GH

Deficient Adults. The Journal of Clinical Endocrinology &

Metabolism, 88(12), pp. 5827–33.

Shimon, I., Taylor, J.E. and Dong, J.Z., 1997. Somatostatin receptor

subtype specificity in human fetal pituitary cultures. Differential role

of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating

hormone, and prolactin regulation. J Clin Invest, 99, pp. 789-98.

Sircili, M.H.P., de Mendonca, B.B., Denes, F.T., Madureira, G., Bachega,

T.A.S.S. and de Querioz e Silva, F.A., 2006. Anatomical and

function outcomes of feminizing genitoplasty for ambiguous

genitalia in patient with virilizing congenital adrenal hyperplasia.

Clinics, 61(3), pp. 209-14.

Sotiropoulos, A., Ohanna, M.I., Kedzia,C.C., Menon, R.K., Kopchick, J.J.

et al, 2006. Growth hormone promotes skeletal muscle cell fusion

independent of IGF-1 up-regulation. Available from :

http://www.pnas.org_cgi_doi_10.1073_pnas.0510033103

Accessed at Dec. 17th 2014


161

Spratt, D.I., Kramer, R.S., Morton, J.R., Lucas, F.L., Becker, K. and

Longscope, C., 2008. Characterization of a prospective human

model for study of the reproductive hormone responses to major

illness. Am J Physiol Endocrinol Metab, 295, pp. 63–9.

Stikkelbroeck, N.M., 2003. Congenital adrenal hyperplasia from childhood

into adulthood. Nijmegen: Drukkerij Quickprint.

Subowo, 2009. Imunobiologi. Edisi 2., CV Sagung Seto, Jakarta.

Takahashi Y., Kipnis D. and Daughhaday, W., 1968. Growth hormone

secretion during sleep. J. Clin invest, 47(9), pp. 2029-90.

Takala, J., Ruokonen, E., Webster, N.R., Nielsen, M.S., Zandstra, D.F.,

Vundelinckx, V., et al., 2011. Increased mortality associated with

growth hormone treatment in critically ill adults. The New England

Journal of Medicine, 341 (11), pp. 785-92.

Takano, A., Usui, I., Haruta, T., Kawahar, K., Uno, T., Iwata, M., et al.,

2001. Mammalian target of rapamycin pathway regulates insulin

signaling via subcellular redistribution of insulin receptor substrate

1 and integrates nutritional signals and metabolic signals of

insulin. Mol Cell Biol, 21(15), pp. 5050-62.

Tham, D.M., Martin-McNulty, B., Wang, Y.X., Wilson, D.W., Vergona, R.,

et al., 2002. Angiotensin II is associated with activation of NF-

kappaB-mediated genes and downregulation of PPARs. Physiol

Genomics.,11(1), pp. 21-30.

Tian, B. and Brasier, A.R., 2003. The Nuclear Factor-kB Gene Regulatory

Network. Critical Care Med, Vol. 31, No 1 (Suppl.)

Tsujimoto, H., Ono, S., Efron, P.A., Scumpia, P.O., Molwader, L.L. and

Mochizuki, H., 2008. Role of Tool-Like Receptors in the

development of sepsis. Shock, 29(3), pp. 315-21.

Van Cauter, E., Latta, F., Nedeltcheva, A., Spiegel, K., Leproult, R,

Vandenbril, C., et al., 2004. Reciprocal interactions between the

GH axis and sleep. Growth Hormone. IGF Res, 14, pp. 10-7.

Van Cauter, E., Plat, L. and Copinschi, G., 1998. Interrelations between

sleep and the somatotrophic axis. Sleep, 21, pp. 553-66.


162

Van Eijk, L. T., Dorresteijn, M. J., Smits, P., van der Hoeven, J. G., Netea,

M. G. & Pickkers, P., 2007. Gender differences in the innate

immune response and vascular reactivity following the

administration of endotoxin to human volunteers. Critical Care

Medicine, Vol. 35, No.6, pp. 1464-1469.

Vanhorebeek, I. and Berghe, G.V.D., 2004. Hormonal and metabolic

strategies to attenuate catabolism in critically ill patients. Current

Opinion in Pharmacology, 4, pp. 621-28.

Vanhorebeek, I. and Berghe, G.V.D., 2006. Neuroendocrine response to

critical illness is a dynamic process. Crit Care Clin, 22, pp. 1-15.

Vanhorebeek, I., Peeters, R.P., Perre, S.V., Jans, I., Wouters, P.J.,

Skogstrand, K., et al., 2006. Cortisol Response to Critical Illness –

Effect of Intensive Insulin Therapy. J Clin Endocrinol Metab, 91,

pp. 3803-13.

Ventetuolo, C.E. and Levy, M., 2008. Biomarkers: Diagnosis and Risk

Assessment in Sepsis. Clin Chest Med, 29, pp. 591–603.

Vigas, M., Malatinsky, J., Nemeth, S. and Jurcovicova, J., 1997. α-

Adrenergic control of growth hormone release during surgical

stress in man. Metabolism, 26, pp. 399-402.

Vincent, J.L. and Abraham, E., 2006. The Last 100 Years of Sepsis. Am J

Respir Crit Care Med, 173, pp 256–63.

Vincent, J.L., Martinez, E.O. and Silva, E., 2009. Evolving Concepts in

Sepsis Definitions. Crit Care Clin, 25, pp. 665–75.

Vogel, T.R., Dombrovskiy, V.Y., Carson, J.L., Graham, A.M., Lowry, S.F.,

2010. Postoperative Sepsis in the United States. Annals of Surgery,

252(6) pp. 1065-1071.

Weekers, F. and Berghe, G.V.D., 2004. Endocrine modifications and

interventions during critical illness. Proceedings of the Nutrition

Society, 63, pp. 443–50.

Weng, Q.P., Kozlowski, M., Belham, C., Zhang, A., Comb, M.J. and

Avruch, J.,1998. Regulation of the p70S6Kinase (p70S6K) by


163

phosphorylation in vivo. Analysis using site-specific anti-

phosphopeptide antibodies. J Biol Chem, 273(26), pp.16621-9.

Wheeler, A.P. and Bernard, G.R., 1999. Treating patients with severe

sepsis. NEJM, 340, pp. 207-14.

Wilson, J., 2003. Harrison’s Principle of Internal Medicine. 12th edition.

New York. McGraw Hill Inc., pp. 1660-2, 1682.

Wren, A.M., Small, C.J., Ward, H.L., Murphy, K.G., Dakin, C.L., Taheri, S.,

et al, 2000. The novel hypothalamic peptide ghrelin stimulates

food intake and growth hormone secretion. Endocrinology,

141(11), pp. 4325-8.

Wu, G., 2009. Amino acids: metabolism, functions, and nutrition. Amino

Acids, 37, pp. 1–17.

Wu, Q., Zhang, T., Cheng, J.F., Kim, Y., Grimwood, J., Schmutz, J. et al.,

2011. Comparative DNA Sequence Analysis of Mouse and Human

Protocadherin Gene Clusters.

Available from : http://genome.org/ Accessed at Dec. 17th, 2014

Wullschleger, S., Loewith, R and Hall, M.N., 2006. TOR signaling in

growth and metabolism. Cell, 124(3), pp. 471-84.

Xu, J.T., Zhao, X., Yaster, M., and Tao, Y.X.; 2010. Expression and

distribution of mTOR, p70S6K, 4E-BP1 and their phosphorylated

counterparts in rat dorsal root ganglion and spinal cord dorsal

horn. Brain Res, 1336C : 46-57.

Yeh, S.S., De Guzman, B. and Kramer, T., 2002. Reversal of COPD-

assosiated weight loss using the anabolic agent oxandrolone.

Chest, 122, pp. 421-28.

Zanchi, N.E. and Lancha, A.H., 2007. Mechanical stimuli of skeletal

muscle: implications on mTOR/p70S6K and protein synthesis. Eur

J Appl Physiol, DOI 10.1007/s00421-007-0588-3.

Zdanowicz, M.M., 2000. Use of Growth Hormone and Insulin-like Growth

Factor-1 for Treatment of Tissue Wasting in Catabolic Conditions.

Hosp Pharmacy, 36(2), pp.163-8.


Documents

DAFTAR PUSTAKA Abbas, AK, Lichtman, AH and Pillai, S., 2012